To the Editor: Autoimmunity has been an undisputed boundary line between type 1 diabetes and other forms of diabetes, including type 2 and MODY, observed in paediatric patients [1], although recent evidence should lead us to reconsider this boundary carefully. …
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.